Summary:
Cionic startup developed a wearable technology embedded in clothing to assist individuals with mobility issues. The device, known as the Neural Sleeve, employs sensors to monitor gait and small electrodes to stimulate leg muscles, aiding in walking.
Initially designed for stroke patients, the Neural Sleeve has proven beneficial for those with multiple sclerosis, cerebral palsy, or recovering from a stroke. The technology enhances endurance and independence, allowing users to walk further and engage in daily activities more comfortably.
By the end of 2019, Cionic, had a working prototype. His daughter was his first product tester, and when the pandemic hit, temporarily became his only tester until larger trials could resume. By 2021, the final design, called the Neural Sleeve, had been submitted to the FDA. It was approved in 2022, and earlier this year, it came to market. Depending on someone’s needs, it might be worn on one leg or both.
Cionic, Robison’s startup, offers the Neural Sleeve through a subscription model, charging $200 per month for 12 months. Although not typically covered by health insurance, this approach aims to make the device more accessible. Enable Ventures, a venture capital firm focused on assistive technology, supports Cionic and other companies addressing unique market opportunities to empower individuals with tools for self-determination and independence. The firm received a $5 million investment from UnitedHealth Group, showcasing growing interest in technologies that enhance accessibility and inclusivity.
Article written by Adele Peters| Image by Cionic
13/11/2023
Source:
Fast Company
https://www.fastcompany.com/90980834/these-bionic-tights-make-it-easier-for-patients-with-ms-to-walk?partner=rss&utm_source=feedly&utm_medium=feed&utm_campaign=rss+fastcompany&utm_content=rss